Amide conjugates of the DO3A-N-(α-amino)propionate ligand: leads for stable, high relaxivity contrast agents for MRI?

Gold nanoparticles functionalised with stable, fast water exchanging Gd3+ chelates as high relaxivity contrast agents for MRI

(2012) M. F. Ferreira et al.   DALTON TRANSACTIONS

Imaging patients with kidney disease in the era of NSF: can it be done safely?

(2011) V. Manjunath et al.   CLINICAL NEPHROLOGY

Gadolinium DOTA Chelates Featuring Alkyne Groups Directly Grafted on the Tetraaza Macrocyclic Ring: Synthesis, Relaxation Properties, “Click” Reaction, and High-Relaxivity Micelles

(2011) Christian Vanasschen et al.   INORGANIC CHEMISTRY

Towards highly efficient, intelligent and bimodal imaging probes: Novel approaches provided by lanthanide coordination chemistry

(2010) Célia S. Bonnet et al.   COMPTES RENDUS CHIMIE

How to measure the transmetallation of a gadolinium complex

(2010) S. Laurent et al.   Contrast Media & Molecular Imaging

Pushing the Sensitivity Envelope of Lanthanide-Based Magnetic Resonance Imaging (MRI) Contrast Agents for Molecular Imaging Applications

(2009) Silvio Aime et al.   ACCOUNTS OF CHEMICAL RESEARCH

Gd(DO3A-N-α-aminopropionate): a versatile and easily available synthon with optimized water exchange for the synthesis of high relaxivity, targeted MRI contrast agents

(2009) Miguel F. Ferreira et al.   CHEMICAL COMMUNICATIONS

Influence of molecular parameters and increasing magnetic field strength on relaxivity of gadolinium- and manganese-based T1contrast agents

(2009) Peter Caravan et al.   Contrast Media & Molecular Imaging

Lanthanide chelates of (bis)-hydroxymethyl-substituted DTTA with potential application as contrast agents in magnetic resonance imaging

(2009) Sara Silvério et al.   DALTON TRANSACTIONS

A new bifunctional GdIII complex of enhanced efficacy for MR-molecular imaging applications

(2009) Lorenzo Tei et al.   DALTON TRANSACTIONS

Toxicity of MRI and CT contrast agents

(2009) Kendra M Hasebroock et al.   Expert Opinion on Drug Metabolism & Toxicology

Gadolinium-based contrast agents and nephrogenic systemic fibrosis: Why did it happen and what have we learned?

(2009) Jeffrey C. Weinreb et al.   JOURNAL OF MAGNETIC RESONANCE IMAGING

Nephrogenic Systemic Fibrosis: History and Epidemiology

(2009) Henrik S. Thomsen   RADIOLOGIC CLINICS OF NORTH AMERICA

Efficiency, thermodynamic and kinetic stability of marketed gadolinium chelates and their possible clinical consequences: a critical review

(2008) Marc Port et al.   BIOMETALS

In vivo MRI assessment of a novel GdIII-based contrast agent designed for high magnetic field applications

(2008) Paulo Loureiro de Sousa et al.   Contrast Media & Molecular Imaging

Extracellular gadolinium contrast agents: Differences in stability

(2008) S.K. Morcos   EUROPEAN JOURNAL OF RADIOLOGY

Synthesis, Potentiometric, Kinetic, and NMR Studies of 1,4,7,10-Tetraazacyclododecane-1,7-bis(acetic acid)-4,10-bis(methylenephosphonic acid) (DO2A2P) and its Complexes with Ca(II), Cu(II), Zn(II) and Lanthanide(III) Ions

(2008) Ferenc K. Kálmán et al.   INORGANIC CHEMISTRY

Nephrogenic Systemic Fibrosis: A Chemical Perspective

(2008) Neil M. Rofsky et al.   RADIOLOGY